Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-04-12 Sale |
2023-04-14 6:23 pm |
Cullinan Oncology Inc. | CGEM | Michaelson Jennifer Chief Development Officer |
176 | $10.22 | $1,799 | 91,117 (Direct) |
View |
| 2023-03-20 Sale |
2023-03-27 4:05 pm |
Cullinan Oncology Inc. | CGEM | Trigilio Jeffrey Chief Financial Officer |
399 | $11.32 | $4,517 | 88,003 (Direct) |
View |
| 2023-03-20 Sale |
2023-03-27 4:05 pm |
Cullinan Oncology Inc. | CGEM | Jones Jeffrey Alan Chief Medical Officer |
390 | $11.32 | $4,415 | 59,610 (Direct) |
View |
| 2023-03-20 Sale |
2023-03-27 4:05 pm |
Cullinan Oncology Inc. | CGEM | Michaelson Jennifer Chief Development Officer |
238 | $11.32 | $2,694 | 91,293 (Direct) |
View |
| 2023-03-20 Sale |
2023-03-27 4:05 pm |
Cullinan Oncology Inc. | CGEM | SUMER JACQUELYN L Chief Legal Officer |
305 | $11.32 | $3,453 | 46,695 (Direct) |
View |
| 2023-03-23 Sale |
2023-03-27 4:05 pm |
Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO |
706 | $10.51 | $7,420 | 118,004 (Direct) |
View |
| 2022-11-25 Sale |
2022-11-29 4:05 pm |
Cullinan Oncology Inc. | CGEM | Michaelson Jennifer See Remarks |
4,000 | $13.3 | $53,200 | 253,624 (Direct) |
View |
| 2022-09-27 Sale |
2022-09-29 4:05 pm |
Cullinan Oncology Inc. | CGEM | Michaelson Jennifer See Remarks |
4,000 | $12.4 | $49,600 | 257,624 (Direct) |
View |
| 2022-08-08 Sale |
2022-08-09 5:36 pm |
Cullinan Oncology Inc. | CGEM | Michaelson Jennifer Chief Development Officer |
1,385 | $15.01 | $20,789 | 261,624 (Direct) |
View |
| 2022-08-02 Sale |
2022-08-04 9:01 pm |
Cullinan Oncology Inc. | CGEM | F2 Vision SCS Jovan-Embiricos Morana 10% Owner |
49,910 | $14.26 | $711,676 | 4,476,350 (Indirect Direct) |
View |
| 2022-07-25 Sale |
2022-07-26 5:44 pm |
Cullinan Oncology Inc. | CGEM | Michaelson Jennifer Chief Development Officer |
8,000 | $14.51 | $116,080 | 263,009 (Direct) |
View |
| 2022-07-18 Sale |
2022-07-21 4:30 pm |
Cullinan Oncology Inc. | CGEM | Savill Corrine Acting Chief Business Officer |
20,000 | $15.18 | $303,593 | 149,615 (Direct) |
View |
| 2022-07-11 Sale |
2022-07-12 4:14 pm |
Cullinan Oncology Inc. | CGEM | Savill Corrine Acting Chief Business Officer |
40,000 | $13.33 | $533,304 | 169,615 (Direct) |
View |
| 2022-06-21 Sale |
2022-06-23 6:47 pm |
Cullinan Oncology Inc. | CGEM | F2 Bioscience I 2017 Ltd Jovan-Embiricos Morana 10% Owner |
101,903 | $12.8 | $1,304,816 | 4,430,964 (Indirect Direct) |
View |
| 2022-06-06 Purchase |
2022-06-07 4:33 pm |
Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO |
8,090 | $12.4 | $100,316 | 8,090 (Direct) |
View |
| 2022-06-01 Purchase |
2022-06-03 6:24 pm |
Cullinan Oncology Inc. | CGEM | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
751,396 | $11 | $8,264,905 | 364,161 (Direct) |
View |
| 2022-05-12 Sale |
2022-05-16 8:54 pm |
Cullinan Oncology Inc. | CGEM | F2 Vision SCS Jovan-Embiricos Morana 10% Owner |
418,738 | $9.6619 | $4,045,791 | 4,532,867 (Indirect Direct) |
View |
| 2022-05-12 Purchase |
2022-05-16 7:34 pm |
Cullinan Oncology Inc. | CGEM | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
1,109,900 | $9.0674 | $10,063,937 | 319,415 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-22 Option Award |
2023-02-23 5:06 pm |
N/A 2033-02-21 |
Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO |
320,000 | $0 | 329,710 (Direct) |
View |
| 2023-02-17 Option Award |
2023-02-21 7:01 pm |
N/A 2033-02-16 |
Cullinan Oncology Inc. | CGEM | Trigilio Jeffrey Chief Financial Officer |
140,500 | $0 | 181,902 (Direct) |
View |
| 2023-02-17 Option Award |
2023-02-21 6:57 pm |
N/A 2033-02-16 |
Cullinan Oncology Inc. | CGEM | Savill Corrine Chief Business Officer |
61,500 | $0 | 211,115 (Direct) |
View |
| 2023-02-17 Option Award |
2023-02-21 6:54 pm |
N/A 2033-02-16 |
Cullinan Oncology Inc. | CGEM | SUMER JACQUELYN L Chief Legal Officer |
140,500 | $0 | 140,500 (Direct) |
View |
| 2023-02-17 Option Award |
2023-02-21 6:53 pm |
N/A 2033-02-16 |
Cullinan Oncology Inc. | CGEM | Baeuerle Patrick Chief Scientific Officer |
115,500 | $0 | 494,434 (Direct) |
View |
| 2023-02-17 Option Award |
2023-02-21 6:52 pm |
N/A 2033-02-16 |
Cullinan Oncology Inc. | CGEM | Michaelson Jennifer Chief Development Officer |
115,500 | $0 | 168,531 (Direct) |
View |
| 2023-02-17 Option Award |
2023-02-21 6:51 pm |
N/A 2033-02-16 |
Cullinan Oncology Inc. | CGEM | Jones Jeffrey Alan Chief Medical Officer |
180,000 | $0 | 180,000 (Direct) |
View |
| 2021-12-21 Ownership |
2023-02-10 4:26 pm |
N/A 2030-10-28 |
Cullinan Oncology Inc. | CGEM | GADICKE ANSBERT Former Director Director 10% Owner |
350,938 | $0 | 8,243,757 (Direct) |
View |
| 2021-12-21 Ownership |
2023-02-10 4:26 pm |
N/A N/A |
Cullinan Oncology Inc. | CGEM | GADICKE ANSBERT Former Director Director 10% Owner |
350,938 | $4.3 | 8,243,757 (Direct) |
View |
Ownership |
2023-02-10 4:26 pm |
N/A N/A |
Cullinan Oncology Inc. | CGEM | GADICKE ANSBERT Former Director Director 10% Owner |
0 | $0 | 8,243,757 (Indirect) |
View |
| 2023-01-19 Other |
2023-01-19 6:30 pm |
N/A N/A |
Cullinan Oncology Inc. | CGEM | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
7,040,000 | $0 | 7,104,161 (Direct) |
View |
| 2022-12-30 Option Award |
2023-01-06 1:48 pm |
N/A N/A |
Cullinan Oncology Inc. | CGEM | Trigilio Jeffrey Chief Financial Officer |
201 | $8.97 | 41,402 (Direct) |
View |
| 2022-11-25 Exercise |
2022-11-29 4:05 pm |
N/A 2030-10-28 |
Cullinan Oncology Inc. | CGEM | Michaelson Jennifer See Remarks |
4,000 | $0 | 253,624 (Direct) |
View |
| 2022-11-25 Exercise |
2022-11-29 4:05 pm |
N/A N/A |
Cullinan Oncology Inc. | CGEM | Michaelson Jennifer See Remarks |
4,000 | $4.3 | 253,624 (Direct) |
View |
| 2022-11-01 Option Award |
2022-11-02 4:36 pm |
N/A 2032-10-31 |
Cullinan Oncology Inc. | CGEM | Ryan David P. Director |
26,150 | $0 | 26,150 (Direct) |
View |
| 2022-09-27 Exercise |
2022-09-29 4:05 pm |
N/A 2030-10-28 |
Cullinan Oncology Inc. | CGEM | Michaelson Jennifer See Remarks |
4,000 | $0 | 257,624 (Direct) |
View |
| 2022-09-27 Exercise |
2022-09-29 4:05 pm |
N/A N/A |
Cullinan Oncology Inc. | CGEM | Michaelson Jennifer See Remarks |
4,000 | $4.3 | 257,624 (Direct) |
View |
| 2022-08-15 Option Award |
2022-08-16 5:07 pm |
N/A 2032-08-14 |
Cullinan Oncology Inc. | CGEM | SUMER JACQUELYN L Chief Legal Officer |
190,000 | $0 | 190,000 (Direct) |
View |
| 2022-08-08 Exercise |
2022-08-09 5:36 pm |
N/A 2030-10-28 |
Cullinan Oncology Inc. | CGEM | Michaelson Jennifer Chief Development Officer |
1,385 | $0 | 261,624 (Direct) |
View |
| 2022-08-08 Exercise |
2022-08-09 5:36 pm |
N/A N/A |
Cullinan Oncology Inc. | CGEM | Michaelson Jennifer Chief Development Officer |
1,385 | $4.3 | 261,624 (Direct) |
View |
| 2022-07-25 Exercise |
2022-07-26 5:44 pm |
N/A 2030-10-28 |
Cullinan Oncology Inc. | CGEM | Michaelson Jennifer Chief Development Officer |
8,000 | $0 | 263,009 (Direct) |
View |
| 2022-07-25 Exercise |
2022-07-26 5:44 pm |
N/A N/A |
Cullinan Oncology Inc. | CGEM | Michaelson Jennifer Chief Development Officer |
8,000 | $4.3 | 263,009 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 6:10 pm |
N/A N/A |
Cullinan Oncology Inc. | CGEM | Michaelson Jennifer Chief Development Officer |
1,620 | $10.9 | 53,031 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 6:08 pm |
N/A N/A |
Cullinan Oncology Inc. | CGEM | Trigilio Jeffrey Chief Financial Officer |
1,451 | $10.9 | 41,201 (Direct) |
View |
| 2022-06-30 Option Award |
2022-07-05 6:04 pm |
N/A N/A |
Cullinan Oncology Inc. | CGEM | AHMED NADIM President and CEO |
1,620 | $10.9 | 9,710 (Direct) |
View |
| 2022-06-24 Tax Withholding |
2022-06-28 9:24 pm |
N/A N/A |
Cullinan Oncology Inc. | CGEM | Jovan-Embiricos Morana 10% Owner |
45,078 | $13.39 | 4,526,260 (Direct) |
View |
| 2022-06-24 Exercise |
2022-06-28 9:24 pm |
N/A 2022-06-30 |
Cullinan Oncology Inc. | CGEM | Jovan-Embiricos Morana 10% Owner |
140,374 | $0 | 4,526,260 (Direct) |
View |
| 2022-06-24 Exercise |
2022-06-28 9:24 pm |
N/A N/A |
Cullinan Oncology Inc. | CGEM | Jovan-Embiricos Morana 10% Owner |
140,374 | $4.3 | 4,526,260 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-23 6:23 pm |
N/A 2032-06-21 |
Cullinan Oncology Inc. | CGEM | Ebeling Thomas Director |
16,475 | $0 | 16,475 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-23 6:22 pm |
N/A 2032-06-21 |
Cullinan Oncology Inc. | CGEM | GADICKE ANSBERT Director |
16,475 | $0 | 16,475 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-23 6:18 pm |
N/A 2032-06-21 |
Cullinan Oncology Inc. | CGEM | Webster Stephen W Director |
16,475 | $0 | 16,475 (Direct) |
View |
| 2022-06-22 Option Award |
2022-06-23 6:16 pm |
N/A 2032-06-21 |
Cullinan Oncology Inc. | CGEM | Rosenberg Anthony Director |
16,475 | $0 | 16,475 (Direct) |
View |